DETERMINANTS OF OXALATE BALANCE IN PATIENTS ON CHRONIC PERITONEAL-DIALYSIS

被引:21
作者
MARANGELLA, M [1 ]
BAGNIS, C [1 ]
BRUNO, M [1 ]
PETRARULO, M [1 ]
GABELLA, P [1 ]
LINARI, F [1 ]
机构
[1] OSPED MAURIZIANO UMBERTO 1,DIV NEPHROL,I-10128 TURIN,ITALY
关键词
OXALATE; OXALOSIS; END-STAGE RENAL FAILURE; CHRONIC PERITONEAL DIALYSIS; PROTEIN INTAKE; PYRIDOXINE; ASCORBIC ACID;
D O I
10.1016/S0272-6386(12)80271-X
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We assessed plasma levels and removal rates of oxalate in 24 patients on chronic peritoneal dialysis (CPD) for oxalosis-unrelated renal failure. The ion-chromatographic (IC) measurements of oxalate in plasma, dialysate, and urine (in seven patients with residual renal function) were used to calculate peritoneal and renal clearances of oxalate. The serum state of saturation with calcium oxalate was calculated by means of a computer-based model system. Patient data were compared with those from 19 healthy individuals. Peritoneal clearance of oxalate was 6.3 ± 4.7 mLJ min, ie, 8% of the normal renal clearance. As a result, both plasma oxalate and calcium oxalate saturation were higher than in controls and did not overlap. Plasma was supersaturated with calcium oxalate in only two of 24 patients (8%). Removal of oxalate by dialysis was related to the amount of fluid infused. Overall removal of oxalate (dialysate plus urine) was similar to 24-hour excretion of normal subjects and was taken as a measure of its generation. Oxalate generation rate was dependent on protein (whole and animal) intake, but not on caloric intake or pyridoxine status. Pyridoxine supplementation, 75 and 300 mg daily for 1 month, was not effective in reducing plasma levels or generation rates of oxalate. Residual renal function had a minor influence on oxalate patterns. We conclude that current programs are adequate to maintain oxalate balance in patients on CPD under basic conditions. © 1993, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:419 / 426
页数:8
相关论文
共 56 条
[1]   EFFECT OF VITAMIN-B6 ADMINISTRATION ON ELEVATED PLASMA OXALIC-ACID LEVELS IN HEMODIALYZED PATIENTS [J].
BALCKE, P ;
SCHMIDT, P ;
ZAZGORNIK, J ;
KOPSA, H ;
DEUTSCH, E .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1982, 12 (06) :481-483
[2]  
BALCKE P, 1985, P EUR DIAL TRANSPLAN, V22, P147
[3]   CAPD WITH AN AMINO-ACID DIALYSIS SOLUTION - A LONG-TERM, CROSSOVER STUDY [J].
BRUNO, M ;
BAGNIS, C ;
MARANGELLA, M ;
ROVERA, L ;
CANTALUPPI, A ;
LINARI, F .
KIDNEY INTERNATIONAL, 1989, 35 (05) :1189-1194
[4]   PRIMARY OXALOSIS MIMICKING HYPERPARATHYROIDISM DIAGNOSED AFTER LONG-TERM HEMODIALYSIS [J].
CANAVESE, C ;
SALOMONE, M ;
MASSARA, C ;
BARBOS, MP ;
CADARIO, A ;
PAVAN, I ;
MARANGELLA, M ;
PETRARULO, M ;
ROTOLO, U .
AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 (04) :344-349
[5]  
COLTART DJ, 1971, BRIT HEART J, V33, P315
[6]   PLASMA-LEVEL AND RENAL CLEARANCE OF OXALATE IN NORMAL SUBJECTS AND IN PATIENTS WITH PRIMARY HYPEROXALURIA OR CHRONIC RENAL-FAILURE OR BOTH [J].
CONSTABLE, AR ;
JOEKES, AM ;
KASIDAS, GP ;
OREGAN, P ;
ROSE, GA .
CLINICAL SCIENCE, 1979, 56 (04) :299-304
[7]   ASCORBIC-ACID INTAKE, RENAL-FUNCTION, AND URINARY OXALATE EXCRETION [J].
CONYERS, RAJ ;
BAIS, R ;
ROFE, AM ;
POTEZNY, N ;
THOMAS, DW .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1985, 15 (03) :353-355
[8]  
FABER SR, 1963, AM J CLIN NUTR, V12, P406
[9]  
FAYEMI AO, 1979, ARCH PATHOL LAB MED, V103, P58
[10]  
FITURI N, 1984, UROL RES, V12, P43